NVIV insider transactions
InVivo Therapeutics Holdings Corp (NVIV) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
NVIV insiders
Everyone who has filed a Form 3, 4, 5 or 144 at InVivo Therapeutics Holdings Corp, latest first. Follow anyone to get their next filing.
- Brice Foose10% owner, since April 2023-$123K
- Richard ChristopherOfficer
- Richard M. ToselliOfficer, Director
- Bob RosenthalDirector, since November 2019
- Richard John RobertsDirector
- Heather HamelOfficer, since July 2022
- Daniel R MarshakDirector
- C Ann MerrifieldDirector
- Christina MorrisonDirector
Recent Form 3, 4, and 5 filings for NVIV
- Foose Brice sold $123,030 worth of InVivo Therapeutics Holdings Corp (330,000 units at $0.37), closing all direct ownership in the company (SEC Form 4) (Amendment)4/A - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- Foose Brice closing all direct ownership in the company (SEC Form 4)4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 3: New insider Foose Brice claimed ownership of 330,000 units of InVivo Therapeutics Holdings Corp3 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4 filed by Christopher Richard4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4 filed by Toselli Richard M.4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4 filed by Rosenthal Bob4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4 filed by Roberts Richard John4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4 filed by Hamel Heather4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4 filed by Marshak Daniel R4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4 filed by Merrifield C Ann4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4 filed by Morrison Christina4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 3: New insider Hamel Heather claimed ownership of 750 shares3 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4: Toselli Richard M. covered exercise/tax liability with 16 shares, decreasing direct ownership by 0.26% to 6,201 units (tax liability)4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4: Toselli Richard M. covered exercise/tax liability with 21 units of Common Stock, decreasing direct ownership by 0.34% to 6,217 units (withholding obligation)4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4 filed by Richard Christopher4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4 filed by M. Richard Toselli4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4 filed by R Daniel Marshak4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4 filed by Christina Morrison4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4 filed by John Richard Roberts4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4 filed by Bob Rosenthal4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 4 filed by Ann C Merrifield4 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)
- SEC Form 3 filed by Bob Rosenthal3 - INVIVO THERAPEUTICS HOLDINGS CORP. (0001292519) (Issuer)